Placerville, CA — Throughout the summer the El Dorado County Medical Marijuana Advisory
Committee will be meeting to discuss different topics regarding medical marijuana. The following are
the dates and topics of the meetings:
Each meeting will take place in the El Dorado County Board of Supervisors Meeting Room at 330 Fair
Lane, Placerville in County Building A.
The committee is comprised of two members of the El Dorado County Board of Supervisors. The
committee members will be collecting information at each of the meetings from different stakeholder
groups, members of the public and County departments regarding each meeting topic (e.g. cultivation,
Members of stakeholder groups that would like to speak at one of the meetings are requested to email
the County at the following email address: mailto:firstname.lastname@example.org There will also
be time available at each meeting for public comment.
Background Information on the Medical Marijuana Advisory CommitteeThe El Dorado County Board of Supervisors created the ad hoc advisory committee at its March 15th
2016 special meeting regarding medical marijuana. During the special meeting, the Board of
Supervisors received an overview on the current medical marijuana laws and reports from County
departments, stakeholder groups and the public on how medical marijuana policy decisions could
affect them. At the conclusion of the meeting, the Board of Supervisors created the ad hoc Medical
Marijuana Advisory Committee to collect more information on different medical marijuana topics (e.g.
cultivation, dispensaries, compliance, etc.).
The County did not conduct meetings regarding medical marijuana in 2015 due to the major statutory
overhauls undertaken by the State of California that resulted in the Medical Marijuana Regulation and
Safety Act (MMRSA), signed in October 2015 and amended in February 2016. The County decided to
wait before pursuing updated medical marijuana ordinances to ensure that any updates were
consistent with the new State laws and regulations.
At the first Medical Marijuana Advisory Committee meeting on May 2nd, the committee discussed the
structure of the future meetings and future meeting dates. In addition, stakeholder groups and the
public talked about their motivation for attending the committee meetings and what outcomes they are
looking for in the process.